NAUČNI KARTON UPOSLENIKA

Size: px
Start display at page:

Download "NAUČNI KARTON UPOSLENIKA"

Transcription

1 1. Osnovni podaci Prezime Univerzitetski klinički centar u Sarajevu NAUČNI KARTON UPOSLENIKA BILALOVIĆ Institut za naučnoistraživački rad i razvoj Ime NURIJA Godina rođenja 1962 Mjesto rođenja Država rođenja Zvanje Titula E mail Trebinje Bosna i Hercegovina Doktor medicine, Doktor medicinskih nauka, specijalista patolog Docent nurija62@gmail.com Telefon/Faks / Telefon lokal 8509 Organizaciona jedinica - Disciplina UKC Klinička patologija i citologija Dijagnostička disciplina 2.Podaci o stečenim diplomama Godina Mjesto Naziv rada Fakultet/Univerzitet Naučna oblast Diploma 1987 Sarajevo Med.fak/UNSA Magisterij Sarajevo Značaj imunohistohemije i kliničkih podataka u dijagnostici malignih limfoma klasificiranih po R.E.A.L.- Med.fak/UNSA Hematologija Doktorat Sarajevo Uloga transkriptivnog faktora PU.1 u folikularnom limfomu. Med.fak/UNSA Hematologija Godina Mjesto Naziv Specijalizacija 1998 Sarajevo Anatomska patologija Subspecijalizacija 1

2 3.Podaci o izborima u nastavničko/saradničko zvanje (navoditi od posljednjeg izbora u zvanje) Godina izbora Naziv zvanja Fakultet/Univerzitet Predmet Naučna oblast 2014 Docent SSST Medical School Histologija i Embriologija Histologija i Embriologija 2010 Docent Fakultet zdravstvenih studija Banja Luka/ Panevropski Univerzitet Apeiron Osnovi patologije Patologija 2010 Docent Fakultet zdravstvenih studija Sarajevo/ Univerzitet Sarajevo 2003 Viši asistent Medicinski fakultet, Univerziteta u Sarajevu. Disfunkcija ljudskog organizma Institut i katedra za patologiju Patologija Institut i katedra za patologiju 4. Usmjerena/kontinuirana edukacija (naziv, trajanje, godina, mjesto) Godina Mjesto Trajanje Naziv 1995 Institutu za patologiju Zagreb, Medicinsko Sveučilište 1995 Onkološki Institut, odjel za patologiju-ljubljana 1999 Copenhagen, Univerzitetska bolnica Herlev 1997 Onkološki Institut, odjel za patologiju-ljubljana 2000 Onkološki Institut, odjel za patologiju-ljubljana 2002 Onkološki Institut, odjel za patologiju-ljubljana 2002 The Radium Hospitale Oslo 2002/2003 The Radium Hospitale Oslo 4 mjeseca Edukacija iz patologije u sklopu specijalizacije 1 mjesec Edukacija iz patologije u sklopu specijalizacije 3 mjeseca Edukacija iz hematopatologije pod mentorstvom prof dr Elisabeth Ralfkiær 1 mjesec Edukacija iz hematopatologije pod mentorstvom dr Janez Jancar 1 mjesec Edukacija iz hematopatologije pod mentorstvom dr Andrea Zidar 1 mjesec Edukacija iz hematopatologije pod mentorstvom dr Janez Jancar i dr Andrea Zidar 3 mjeseca Gost The Radium Hospitale Oslo, edukacija iz hematopatologije mentori Prof dr Jahn Delabie i Dr. Emina Torlaković 7 mjeseci Stipendista Norveške vlade, Istraživačkog vijeća Norveške iz oblasti hematopatologije 2

3 5. Objavljeni radovi (navoditi od posljednjeg objavljenog rada) 5.1 Originalni/naučni radovi 1. Skenderi F, Ulamec M, Vranic S, Bilalovic N, Peckova K, Rotterova P, Kokoskova B, Branzovsky J, Michal M, Hes O. Cystic renal oncocytoma and tubulocystic renal cell carcinoma: Morphologicaland immunohistohemical study. Pathology 2014;46(S2): Konjhodzic R, Dervovic E, Kurtovic-Basic I, Stomornjak-Vukadin M, Muhic A, Baljevic S, Pirnat-Gegic A, Basic E, Bilalovic N. Use of Quantitative Fluorescent Polymerase Chain Reaction (QF PCR) in Prenatal Diagnostic of Fetal Aneuploidies in a 17 Month Period in Parallel with Karyotyping.Acta Inform Med Apr;22(2): Godinjak Z, Bilalovic N.Estrogen and progesterone receptors in endometrium in women with unexplained infertility. Mater Sociomed Feb;26(1): Foco F, Bilalović N, Vranić S, Serdarević F, Ramović I, Imamović E.Peritumoral p53 expression in oral carcinoma. Coll Antropol Nov;36 Suppl 2: Godinjak Z, Bilalović N, Idrizbegović E. Laparoscopic treatment of ovarian dermoid cysts is a safe procedure. Bosn J Basic Med Sci Nov;11(4): Vranic S, Frkovic-Grazio S, Bilalovic N, Gatalica Z. Angiogenesis in adenoid cystic carcinoma of the breast. Virchows Arch 2011;459: Kozarić-Kurtović A, Bilalović N, Gavrankapetanović F. Razvoj citogenetike i molekularne genetike u medicinskoj dijagnostici na Kliničkom Centru Univerziteta u Sarajevu. Med Žurnal 2010; 16 (4, Suppl.1): Vranic S, Frkovic-Grazio S, Lamovec J, Serdarevic F, Gurjeva O, Palazzo J, Bilalovic N, Lee LMJ, Gatalica Z. Adenoid cystic carcinomas of the breast have low Topo IIα expression but frequently over-express EGFR protein without EGFR gene amplification. Hum Pathol 2010;41: Vranic S, Tawfik O, Palazzo J, Bilalovic N, Eyzaguirre E, Lee LMJ, Adegboyega P, Hagenkord J, Gatalica Z. EGFR and HER-2/neu expression in invasive apocrine carcinoma of the breast. Mod Pathol 2010;23: Kundurović Z, Hasanagić S, Bilalović N, Gavrankapetanović F, Aličelebić S. Pro-apoptotic protein Bax and antiapoptic protein Bcl-2 expression in streptozotocin model of Alzheimer s disease. HealthMED 2009; 3(4): Vranic S, Caughron SK, Djuricic S, Bilalovic N, Zaman S, Suljevic I, Lydiatt WM, Emanuel J, Gatalica Z. Hamartomas, teratomas and teratocarcinosarcomas of the head and neck: Report of 3 new cases with clinicopathologic correlation, cytogenetic analysis, and review of the literature.bmc Ear Nose Throat Disord. 2008;8:8 12. Cukić V, Lovre V, Beslić S, Bilalović N, Guska S.Lung lymphangioleiomyomatosis (LAM). Med Arh. 2008;62(3): Torlakovic EE, Slipicevic A, Flørenes VA, Chibbar R, DeCoteau JF, Bilalovic N. Fli-1 expression in malignant melanoma. Histol Histopathol Nov;23(11): Sofic A, Sehovic N, Beslic S, Prnjavorac B, Bilalovic N, Caluk J, Sofic D MR rectum imaging with ultra sound gel as instrumental contrast media in tubulovillous adenomaso RADIOLOGY AND ONCOLOGY VL 42 IS 3 BP 136 EP 142 PY 2008 TC Foco F, Vranic S, Serdarevic F, Cickusic E, Bilalovic N. Peritumoral expression of p53 protein in oral carcinoma and its correlation with relapse. Med Zurnal 2007;13: Vranić S, Bilalović N, Lee LMJ, Krušlin B, Lilleberg S, Gatalica Z. PIK3CA and PTEN mutations in adenoid cystic carcinoma of the breast metastatic to kidney. Hum Pathol 2007;38: Vukobrat-Bijedić Z, Husić-Selimović A, Radović S, Gornjaković S, Gogov B, Zubcević N, Bilalović N, Koluder. Evaluation of hepatitis C virus genotype and its influence on therapeutical respond on combined therapy with pegilated interferon A 2a (40)kD and ribavirin. Med Arh. 2007;61(4):

4 18. Prohic A, Selmanagic A, Bilalovic N. Epidermolytic Hyperkeratosis Type NPS-3: A Case Report. Acta Dermatovenerol Croat. 2007;15(1): Junuzović Dž, Kulovac B, Bilalović N, Bajramović S.PRESERVATION OF RENAL FUNCTION BY EARLY DIAGNOSIS AND TREATMENT OF URETERAL OBSTRUCTION DUE TO IDIOPATHIC RETROPERITONEAL FIBROSIS. Medicinski Žurnal 2007; 13 (3-4): Balta E; Beslic N; Bilalovic N; Beslic Sefik; Secic S; KapetanovicE; Muftic K. SLN operativna tehnika malignih tumora dojke. ACTAINFORMATICA MED. 2006; 14(2): Vranic S, Kapur L, Foco F, Bilalovic N, Hainaut P. The first case of Li-Fraumeni syndrome in Bosnia and Herzegovina: Case report. Pathologica 2006; Torlakovic EE, Bilalovic N, Golouh R, Zidar A, Angel S. Prognostic significance of PU.1 in follicular lymphoma. J Pathol. J Pathol Jul;209(3):352-9 J Pathol Jul;209(3): Bilalovic N, Vranic S, Serdarevic F, Foco F. The role of the stroma in carcinogenesis. Bosn J Basic Med Sci 2006;6(1): Lacevic A, Bilalovic N, Kapic A.Bacterial aggregation in infected root canal. Bosn J Basic Med Sci Nov;5(4): Bilalovic N, Vranic S, Basic H, Tatarevic A, Selak I. Immunohistochemical evaluation of cyclin D1 in breast cancer.croat Med J Jun;46(3): Bilalović N,Vranić S, Hasanagić S, Bašić H, Tatarevic A, Bešlija S, Selak I. The Bcl-2 protein: a prognostic indicator strongly related to ER and PR in breast cancer. Bosnian Journal of basic medical sciences. 2004; 4: Torlakovic E, Bilalovic N, Nesland JM., Torlakovic G, Florenes V. ETS-1 transcription factor is widely expressed in benign and malignant melanocytes and has no association with prognosis. Mod Pathol. 2004;17: Bilalovic N., Blystan A.K., Golouh R., Nesland J.M., Selak I., Trinh D., Torlakovic E. BCL-6 and CD10 protein expression are associated with longer overall survival and time to treatment failure in follicular lymphoma. Am J Clin Pathol. 2004;121: Bilalovic N., Sandstad B., Golouh R., Nesland J.M., Selak I., Torlakovic E. CD10 protein expression in tumor and stromal cells of malignant melanoma is associated with tumor progression. Mod Pathol. 2004;17: Selak I, Bilalovic N, Vranic S, Sabanovic E. Malignant Lymphoma in SarajevoRegion according to WHO Classification in periods (before the war)and (after the war). Radovi Akademije nauka i umjetnosti Bosne I Hercegovine 2003;31: Vuckovic I, Dilberovic F, Kapur E, Voljevica A, Bilalovic N, Selak I. The principles of telemedicine in practice. Bosnian Journal of basic medical sciences. 2003; 4: MAŠIC I, BILALOVIC N, KARCIC S, HADŽIAHMETOVIC Z. Korijeni telemedicine u Bosni i Hercegovini u postdejtonskom periodu. Mat Soc Med, 2002; 14(3-4): Bilaloviċ N., Vidoviċ Z., Telemedicine with respect to telepathology in Bosnia-Herzegovina. Med Arh 1999;53: Vidoviċ Z., Bilaloviċ N., Telemedicine with emphasis on telepathology--its beginnings and future prospects in Bosnia-Herzegovina. Med Arh. 1998;52: Mornjakoviċ Z., Aličelebiċ S., Bilaloviċ N., Šuško I., Morphometric characteristics of Leydig cells in rats treated with melatonin and whole body irradiation. Med Arh 1998;52: Bilaloviċ N., Paties C., Mason A., SHARED ( Satelite Health Access for Remote Environment Demonstrator) project in Bosnia and Herzegovina: benefits of using telemedicine and first results. Journal of Telemedicine and Telecare 1998;4: Vidoviċ Z., Bilaloviċ N., Telepathology and present experience based on use of the SHARED telecommunication project. Med Arh 1997;51:

5 38. Selak I., Bilaloviċ N. Concept of Telepathology in R/F Bosnia and Herzegovina, Electronic Journal of Pathology and Histology.1996;2: Vidoviċ Z., Bilaloviċ N., Babiċ M., Selak I., Šimiċ S., Carcinoma of sweat gland vulve, Med Arh 1996;2: Stručni radovi 1. Konjhodzic R, Dervovic E, Kurtovic-Basic I, Stomornjak-Vukadin M, Muhic A, Baljevic S, Pirnat-Gegic A, Basic E, Bilalovic N. Use of Quantitative Fluorescent Polymerase Chain Reaction (QF PCR) in Prenatal Diagnostic of Fetal Aneuploidies in a 17 Month Period in Parallel with Karyotyping.Acta Inform Med Apr;22(2): Godinjak Z, Bilalovic N.Estrogen and progesterone receptors in endometrium in women with unexplained infertility. Mater Sociomed Feb;26(1): Foco F, Bilalović N, Vranić S, Serdarević F, Ramović I, Imamović E.Peritumoral p53 expression in oral carcinoma. Coll Antropol Nov;36 Suppl 2: Godinjak Z, Bilalović N, Idrizbegović E. Laparoscopic treatment of ovarian dermoid cysts is a safe procedure. Bosn J Basic Med Sci Nov;11(4): Kozarić-Kurtović A, Bilalović N, Gavrankapetanović F. Razvoj citogenetike i molekularne genetike u medicinskoj dijagnostici na Kliničkom Centru Univerziteta u Sarajevu. Med Žurnal 2010; 16 (4, Suppl.1): Obralić N, Kulovac B, Bilalović N, Aganović D. Comparisson of preoperatiove and postoperative stage and grade of prostate carcinoma in patients with PSA level of 2-10 ng/ml. In press LIBRI ONCOLOGY, vol. XXXVI No Vukobrat-Bijedić Z, Husić-Selimović A, Radović S, Gornjaković S, Gogov B, Zubcević N, Bilalović N, Koluder Evaluation of hepatitis C virus genotype and its influence on therapeutical respond on combined therapy with pegilated interferon A 2a (40)kD and ribavirin.med Arh. 2007;61(4): Vranic S, Caughron SK, Djuricic S, Bilalovic N, Zaman S, Suljevic I, Lydiatt WM, Emanuel J, Gatalica Z. Hamartomas, teratomas and teratocarcinosarcomas of the head and neck: Report of 3 new cases with clinicopathologic correlation, cytogenetic analysis, and review of the literature.bmc Ear Nose Throat Disord Sofic A, Sehovic N, Beslic S, Prnjavorac B, Bilalovic N, Caluk J, Sofic D MR rectum imaging with ultra sound gel as instrumental contrast media in tubulovillous adenomaso RADIOLOGY AND ONCOLOGY VL 42 IS 3 BP 136 EP 142 PY 2008 TC Fočo F, Vranić S, Serdarević F, Čičkušić E,Bilalović N. Peritumoral expression of p53 protein in oral carcinoma its correlation with relapse. Medicinski Žurnal (3-4): Lacevic A, Bilalovic N, Kapic A. Bacterial aggregation in infected root canal. Bosn J Basic Med Sci Nov;5(4): Bilaloviċ N., Vidoviċ Z., Telemedicine with respect to telepathology in Bosnia-Herzegovina. Med Arh 1999;53: Vidoviċ Z., Bilaloviċ N., Babiċ M., Selak I., Šimiċ S., Carcinoma of sweat gland vulve, Med Arh 1996;2: Pregledni/revijalni radovi 1. Bilalovic N, Vranic S, Serdarevic F, Foco F. The role of the stroma in carcinogenesis. Bosn J Basic Med Sci 2006;6(1):33-8 5

6 5.4 Prikazi slučajeva 1. Dizdarević K; Bilalović N, Apok V. Neurosurgical Treatment of Sporadic Meningoangiomatosis. PEDIJATRIJA DANAS. 2010; 6(1): Cukić V, Lovre V, Beslić S, Bilalović N, Guska S.Lung lymphangioleiomyomatosis (LAM). Med Arh. 2008;62(3): Prohic A, Selmanagic A, Bilalovic N. Epidermolytic Hyperkeratosis Type NPS-3: A Case Report. Acta Dermatovenerol Croat. 2007;15(1): Vranić S, Kapur L, Fočo F, Bilalović N, Hainaut P. The first case of LiFraumenisyndrome in Bosnia and Herzegovina: Case report. Pathologica2006;98: Vidoviċ Z., Bilaloviċ N., Babiċ M., Selak I., Šimiċ S., Carcinoma of sweat gland vulve, Med Arh 1996;2: Abstrakti (kongresi, simpoziji, konferencije..) 1. Gatalica Z, Bilalovic N, Palazzo J. P., Bender R. P., Millis S, Hoff D Von, Arceci R. J. Disseminated histiocytoses: biomarkers beyond BRAFV600E. Note:American Society of Clinical Oncology Chicago Udovicic-Gagula D, Ahmovic A, Bilalovic N, Doric M. EXPRESSION OF KI-67 AND ESTROGEN RECEPTOR BETA IN PRIMARY MALIGNANT MELANOMA AS A POTENTIAL INDICATOR OF REGIONAL LYMPH NODE POSITIVITY.Pathology-Journal of the RCPA, 2014 (2014), 46(S2) Note: the XXXth Congress of the International Academy of Pathology - IAP Bangkok, Thailand October 5-10, Skenderi F, Ulamec M, Vranic S, Bilalovic N, Peckova K, Rotterova P, Kokoskova B, Branzovsky J, Michal M, Hes O. CYSTIC RENAL ONCOCYTOMA AND TUBULOCYSTIC RENAL CELL CARCINOMA: MORPHOLOGIC AND IMMUNOHISTOCHEMICAL COMPARATIVE STUDY. (2014), 46(S313) Note: the XXXth Congress of the International Academy of Pathology - IAP Bangkok, Thailand October 5-10, Chikha A, Jukovic-Bihorac F, Skenderi F, Krakonja F, Bilalovic N, Vranic S. Infarcted fibroadenoma of the breast: Report of two cases. Histopathology 2012;61(suppl.1):15. Note: XXIX Congress of the International Academy of Pathology. Cape Town, South Africa, September 30 October 5, Bilalović N, Kapetanović A, Chikha A, Hodžić D. APOCRINE CARCINOMA, DOBRO DIFERENCIRANI (SYRINGOCYSTADENOCARCINOMA PAPILLIFERUM) NASTAO U PREEGZISTIRAJUĆEM SYRINGOCYSTADENOMA PAPILLIFERUM I NAEVUS SEBACEUS APOCRINE CARCINOMA WITH GOOD DIFFERENTIATION (PAGE 232). Note:2 CONGRESS OF PATHOLOGISTS IN BOSNIA AND HERZEGOVINA WITH INTERNATIONAL PARTICIPATION May 2012, Banja Luka 6. Bilalovic N, Chika A.,Hodžić D.,Torlaković.,Đuričić S.HEMOFAGOCITNI SINDROM HEMO-FAGOCYTIC SYNDROME (PAGE 243). Note:2 CONGRESS OF PATHOLOGISTS IN BOSNIA AND HERZEGOVINA WITH INTERNATIONAL PARTICIPATION May 2012, 7. Bilalovic N, Hodzic D, Omanovic A, Vranic S. Granulocytic Sarcoma of the Breast. Abstract Book, 2nd Congress of Pathologists in Bosnia and Herzegovina with international participation; pp Note: 2nd Congress of Pathologists in Bosnia and Herzegovina with international participation, Banja Luka, May 10-12, Nurija Bilalović (Sarajevo, BiH): Limfomi probavne cijevi: od morfologije do molekularne biologije. Note:Days of BHAAAS in B&H / Dani BHAAAS u BiH Sarajevo Bilalovic, N, Chika A,Hodžić D,Ibišević N,Torlaković E,Đuričić S. Hemophagocytic syndromes-a case report."histopathology. Vol RIVER ST, HOBOKEN , NJ USA: WILEY-BLACKWELL, 2012Note: The International Academy of Pathology Cape Town Bilalovic, N, Hodzic D, Kurtovic-Kozaric A, Omanovic A, Chika A, Ibisevic N, Vila M, Hafizovic A.S. Myeloid sarcoma: unusual presentation of four cases. In HISTOPATHOLOGY, vol. 61, pp RIVER ST, HOBOKEN , NJ USA: WILEY-BLACKWELL, Note: The International Academy of PathologyCape Town

7 11. Vranic S, Frkovic-Grazio S, Bilalovic N, Gatalica Z. Evaluation of angiogenesis in adenoid cystic carcinoma of the breast. Virchows Arch 2011;459(suppl.1):S84. Note: 23rd European Congress of Pathology, Helsinki, Finland, August 27 September 1, Bilalovic N. Patološki i biološki markeri karcinoma dojke - prognostički i prediktivni značaj. Note: Symposium Savremeni pristup u tretmanu karcinoma dojke, Akademija nauka i umjetnosti Bosne i Hercegovine, November 23, Nurija Bilalovic Needle Biopsy for Noninvasive and Invasive Breast Cancer.Note: 4. Kongres radiologa BiH sa međunarodnim učešćem Vranic S, Frkovic-Grazio S, Bilalovic N, Palazzo J, Gatalica Z. Epidermal Growth Factor Receptors And Topoisomerase II Alpha In Primary Adenoid Cystic Carcinomas Of The Breast. Mod Pathol 2010;23(Suppl.1):76A. Note: United States & Canadian Academy of Pathology Annual Meeting, Washington DC, USA, March 20-26, Merhemić Z, Gavrankapetanović F, Bilalović N, Nikšić M, Kadenić Z, Avdagić E, Thurnher MM. Comparision of 1.5 and 3.0 T Diffusion-Weighted MR Imaging for Brain Tumors. Symposium neuroradiologicum: the world congress of diagnostic and therapeutic neuroradiology, 19th.: Communications; Bologna, Italy. Bologna: s.n.; 2010: 148(full). Notes: The NEURORADIOLOGY JOURNAL, formerly RIVISTA DI NEURORADIOLOGIA, 2010: 148 (full) 16. Dizdarevic K, Omerhodzic I, Bilalovic N. INTRACRANIAL MENINGIOANGIOMATOSIS: A CASE REPORT. FOLIA MEDICA FACULTATIS MEDICINAE UNIVERSITATIS SARAEVIENSIS 2009;44(14-suppl) Note:Morfologija u nauci i praksi" sa međunarodnim učešćem, septembar 2009., Sarajevo, Bosna i Hercegovina 17. Kundurovic Z, Hasanagic S, Bilalovic N, Gavrankapetanovic F. EXPRESSION OF CERTAIN MEMBERS OF BCL-2 FAMILY OF ONCOPROTEINS IN STREPTOZOTOCIN MODEL OF ALZHEIMER S DISEASE 2009;44(28-suppl) Note:Morfologija u nauci i praksi" sa međunarodnim učešćem, septembar 2009., Sarajevo, Bosna i Hercegovina 18. Merhemić Z, Gavrankapetanovic F, Beslija S, Bilalović N, Thurnher MM. Diffusion-weighted MR imaging(dwi) in evaluation of brain tumors: comparasion 1,5 T vs.3.0 T. Neuroradiology (2009) 51 (Suppl 1):99 1. Note 18th Advanced Course& 2nd International Advanced Course, September 17-20, Athens, Greece 19. Hasanagic S, Kundurovic Z, Kucukalic A, Gavrankapetanovic F, Bilalovic N, Petrisic-Salkovic M, RiedererP. Expression of certain apoptotic regulators in a pharmacological experimental model of Alzheimer's disease. The Journal of the European College of Neuropsychopharmacology 2009; 19 ( 3): Lojo-Kadrić N, Kapur L, Ramić J, Bešlija S, Obralić N, Bilalović N, Vranić S, Bajrović K. Identifikacija mutacija na BRCA1 genu u skupini pacijenata sa dijagnozom karcinoma dojke i ovarija prije 40 te godine života. Note: International Scientific Symposium Molecular genetic research today and it's application possibilities. Tuzla, October 11, Ramić J, Kapur L, Lojo Kadrić N, Macić D., Radić K., Bilalović N., Bajrović K.Ekspresija BRCA1 I TP 53 u različitim tipovima tumorskog tkiva (Expression of BRCA1 and TP 53 genes in different types of tumor). Note: MOLECULAR GENETICS RESEARCH TODAY AND IT'S APPLICATION POSSIBILITIES. Tuzla,11. oktobar Kapur Poljskic L, Lojo Kadic N, Ramic J, Macic D, Bilalovic N, Obralic N. Cancer tissue database for the purpose of genetic epidemiology of breast cancer in Bosnia and herzegovina. BOUN Journal 2008; 13, Suppl 1: 15 (abstract PP-34) 23. Bilalovic N, Cimic A, Lazovic E, Cvorak A.CUTANEOUS ROSAI DORFMAN DISEASE WITHOUT LIMPHADENOPATHY A CASE REPORT. Note:Congress dermatovenerology maja 2007, Sarajevo, BiH 24. Lazovic E, Bilalovic N, Cimic A, Bukvic I. DISTANT METASTATIC DISEASE OF SKIN MELANOMA AT OVARY, LIKE PARAOVARY CYST: CASE REPORT. Note:Congress dermatovenerology maja 2007, Sarajevo, BiH 25. Vranić S., Đuričić S., Suljević I., Bilalović N. Unrecognized epignathus followed by airway obstruction as a cause of neonatal death. Acta Clin Croat 2007;46 (suppl. 2):23. Note :17 th Ljudevit Jurak International Symposium on comparative pathology, Juni 1-2, 2007 Zagreb, Croatia 7

8 26. Vranić S, Bilalović N, Ćerimagić Z, Gatti A, Kayser K. Secondary leiomyomatosis in a Bosnian male: A case report. Acta Clin Croat 2006;45(2):163 Note: 17th Ljudevit Jurak International Symposium on Comparative 8 Pathology, Zagreb, Croatia, June 2-3, Kundurovic Z, Hasanagic S, Salkovic-Petrisic M, Bilalovic N, Riederer P. Indications of apoptotic cascade activation in temporal gyrus neurons of rats with experimental cerebral diabetes. Germany Journal of Neural Transmission VL Note: 39th International Danube Symposium for Neurological Science and Continuing Education/1st International Congress on ADHD, from Childhood 28. Ibrulj, S. Heljic S, Bilalovic N. The spectrum of abnormalities in child with de grouchy syndrome type 2. Chromosome Research (2007);15:51-1. Note: CT 6th European Cytogenetics Conference JUL 07-10, 2007 Istanbul, TURKEY 29. Brigić E., Mesihović R., Sabina Kurtagić S., Dizdarević,Brigić A., Bilalović N., Koressov model kancerogeneze i djetinjstvo. Note:Treći kongres pedijatara Mostar Cimic A, Vranic S, Bilalovic N. Virchows Arch 2007; Intraabdominal localization of extraskeletal myxoid chondrosarcoma: Case report. Virchow's Archive. Virchow's Archive. 2007; 451( 2): Note: 21st European Congress of Pathology, Istanbul, Turkey, September 8-13, Vranic S, Cimic A, Pasanovic A, Hodzic D, Bilalovic N. Cyclin D1 and Ki-67 expression in columnar cell lesions of the breast. Virchows Arch Virchow's Archive. 2007; 451( 2): Note: 21st European Congress of Pathology, Istanbul, Turkey, September 8-13, Bilalovic N, Cimic A, Vranic S, Vidovic Z, Kayser K. Pulmonary papillary pneumocytoma (sclerosing hemangioma) and importance of clinical data. Virchow's Archive. Virchow's Archive. 2007; 451( 2): Note: 21st European Congress of Pathology, Istanbul, Turkey, September 8-13, Bilalovic N, Cimic A, Vranic S, Bejtovic I, Chikha A, Gavrankapetanovic F. Endoglin (CD105) expression in nonsmall cell lung cancer and its correlation with EGFR, CD34 and other histopathological parameters: Pilot study. Virchow's Archive. 2007; 451( 2): Note: 21st European Congress of Pathology, Istanbul, Turkey, September 8-13, Gatalica Z., Lee L., Hatcher L., Palazzo J.,Adegboyega P.,Tawfik O. Bilalovic N. Pure apocrine carcinomas of the breast overexpress EGFR and have increased EGFR gene dosage due to polysomy of chromosome Modern Pathol., 2007;Vol 20:(Suppl 2) Note:UNITED STATES AND CANADIAN ACADEMY OF PATHOL OGY,March 24-30, 2007 San Diego, California 35. Fočo F, Vranić S, Serdarević F, Čičkušić E, Gurjeva O, Bilalović N. Peritumoral expression of p53 in oral cancer and its correlation with relapse. Oral Oncol Suppl Vranić S, Lazovic E, Obralic N, Gavrankapetanovic F, Bilalovic N. The correlation of morphological features of transitional cell carcinoma of urinary bladder with different biological parameters. Modern Pathol.2006;19(Suppl.3):88-2. Note:XXVI IAP International Congress, September 16-21, 2006 Montreal, Canada. 37. Vranić S, Muftić K, Bešlić,Bilalović N. Reccurent malignant granular cell tumor of the breast: A case report. Modern Pathol. 2006;19 (Suppl. 3) : Note:XXVI IAP International Congress, September 16-21, 2006 Montreal, Canada. 38. Bilalović N, Šeparović R, Hiroš M, Perić-Balja M, Krušlin B. Adenoid cystic carcinoma of breast metastazing to the kidney: a case report. Modern pathology.2006; Vol 19( Suppl 3):77-1. Note:XXVI IAP International Congress, September 16-21, 2006 Montreal, Canada. 39. Vranic S, Tanovic H, Lazovic E, Pasanovic A, Bilalovic N.Abdominal anaplastic large cell lymphoma with spleen and pancreas involment. Note:First congress of surgery of Federation of Bosnia and Herzegovina. Sarajevo April Bilalovic N, Tanovic M, Adrovic A, Kukavica M, Vranic S.Expression of Cyclin D1in human colorectal cancer (CRC) and its correlation with prognosis. Note:First congress of surgery of Federation of Bosnia and Herzegovina. Sarajevo April

9 41. Balta E,Bešlić N, Bilalović N, Šečić S, Kapetanović E, Muftić K. SLN operativna tehnika malignih tumora dojke. Note:First congress of surgery of Federation of Bosnia and Herzegovina. Sarajevo April Torlakovic E, Slipicevic A, Florenes V, Chibbar R, Bilalovic N. Fli-1 Expression in Malignant Melanoma. Lab Invest 2006;86(Suppl.1):88-1. Note:UNITED STATES AND CANADIAN ACADEMY OF PATHOL OGY, February 11-17, 2006, Atlanta, Georgia. 43. Torlakovic E, Bilalovic N, Glolouh R, et al. Prognostic significance of germinal center (GC) phenotype for outcome in follicular lymphoma. Lab Invest 2005;85(Suppl.1): Note:UNITED STATES AND CANADIAN ACADEMY OF PATHOL OGY, February 11-17, 2006, Atlanta, Georgia. 44. Vuckovic I, Dilberovic F, Obhodzas M, Bilalovic N. Intrafascicular application of Lidocaine 2% or 0.9% NaCl into the medianus nerve of the rat. Reg Anesth Pain Med 2005; 30(3): Bilalovic N, Vranic S. Expression of CD10 in stromal fibroblast in invasive breast cancer. Virchow. 2005; 447 (2);14-1.Note:20th European Congress of Pathology, Paris, September BILALOVIC N, Vranic S. Expression of CD34 as a vascular marker in invasive breast cancer. Book of Abstracts.Note:3 rd Croatian Congress of Pathology, Forensic Medicine, Clinical Cytology in Opatija, Croatia, 8-11 May Bilalović N.,Hasanagić S., Vranić S., Bešlija S., Bašić H., Selak I. Although Bcl-2 expression is associated with better outcome, Bcl-2 is not independent prognosticator of overall survival (OS) and relapse-free survival (RFS) in breast cancer. Eur J Cancer Suppl 2004;3(2): Vranić S, Bilalović N. Cyclin D1 expression in breast cancer. Abstractbook of «15th ESC», Berlin, Germany, October 19-23, Bilalovic N, Vranic S, Hasanagic S, Basic H,Tatarevic A, Selak I. Cyclin D1 is good prognosticator in breast cancer, Acta clinica Croatica 2004;Vol 43(2): 93-1.(rad nagrađen kao najbolji rad simpozijuma). Notes:15 th Ljudevit Jurak International Symposium on comparative pathology, Juni 4-5, Zagreb, Croatia 50. Bilalovic N, Vranic S., Hasanagic S., Selak I. Epstein-barr virus expression in breast cancer Acta clinica Croatica 2004;Vol 43(2),92-1. Notes:15 th Ljudevit Jurak International Symposium on comparative pathology, Juni 4-5, Zagreb, Croatia 51. Basic H, Bilalovic N, Vranic S, Tatarevic A. Estrogen and Progesterone receptor expression more precisely determined by monoclonal H-score immunohistochemistry than by polyclonal antibodies, impact on breast cancer outcome. Cancer control in developing countries, 2004: Notes: Annual Meeting 2004, Cancer control in developing countries, Translating Knowledge into Effective Action, Cairo, Egypt, October 2 nd -5 th, Basic H, Bilalovic N, Tatarevic A, Vranic S. Correlation between the prognostic value of Bcl-2 and standard clinical and histopathological parametres in breast cancer patients. Ann Oncol 2004;15(Suppl.3):iii58 (No. 219P). ANNALS OF ONCOLOGY 15, Notes: 29th ESMO Congress, Vienna, Austria, 29.Oct-2.Nov Bilalovic N., Anne Kirsti Blystad, Golouh R., Nesland J.M., Selak I., Torlakovic E. Prognostic value of grading in follicular lymphoma.notes: Morphology in science and praxis, Sarajevo, September 25-27, Bilalovic N., Berbic-Fazlagic J., Robovic Z., Vranic S., Cikic B., Selak I. Immunohistochemical analysis significance in diagnostic assessment of malignant lymphoma.notes: Morphology in science and praxis, Sarajevo, September 25-27, Bilalovic N., Golouh R., Nesland J.M., Selak I., Torlakovic E. BCL-6 and CD10 protein expressions are prognostic factors of overall survival and time to treatment failure in follicular lymphoma. Virchows Archiv, Volume 443, Number 3,2003, Pages: Notes: 19th ECP, Ljubljana, Slovenia, September 6-11, Bilalovic N., Golouh R., Nesland J.M., Selak I., Torlakovic E. Follicular lymphoma grading by Mann and Berard are predictive of overall survival and time to treatment failure, however, only grade 1 has favorable OS and TTF. Virchows Archiv, Volume 443, Number 3,2003Pages: Notes: 19th ECP, Ljubljana, Slovenia, September 6-11, Bilalovic N., Golouh R., Nesland J.M., Selak I., Torlakovic E. In malignant melanoma CD10 protein expressions 9

10 is associated with metastatic tumors higher Clark levels and tumor thickness according to Breslow. Virchows Archiv, Volume 443, Number 3,2003, Pages: Note: 19th ECP, Ljubljana, Slovenia, September 6-11, Vuckovic I, Mulabdic V, Bilalovic N. Telemedicine in relation to telepathology in Bosnia and Herzegovina Note: First Congress of Medical Informatics, Sarajevo 6th World Congress on the Internet in Medicine. 59. Bilaloviċ N., Selak I., Taccagni G.,Paties C., Fontanella G.SHARED (Satellite Health Access for Remote Environment Demonstrator), project in Bosnia and Herzegovina: benefits of using telemedicine and first results. Journal of Telemedicine and Telecare1998;4:91-3. Notes: Royal Society of Medicine, London, 26. November Bilaloviċ N., Babiċ M., Selak I., Taccagni G.,Paties C., Fontanella G., Telemedicine project (SHARED) in R/F Bosnia and Herzegovina : First results of its use in histopathological diagnosis, Analytical Cellular Pathology Notes :( AWARDED IN OSLO ON THE 5 CONGRESS ESACP) 61. Mornjakoviċ Z., Aličelebiċ S., Bilaloviċ N., Šuško I.,Morphometric characteristics of Leydig cells in rats treated with melatonin and whole body irradiation. Notes: 7th European Congress for stereology. Amsterdam 20-23, April Selak I., Bilaloviċ N.Concept of Telepathology in R/F Bosnia and Herzegovina, Electronic Journal of Pathology and Histology.Notes: Second Congress of Telepathlogy, Zagreb Objavljene publikacije (knjige, udžbenici, monografije, vodiči, praktikumi) Naziv publikacije Obralić N. REGISTAR MALIGNIH NEOPLAZMI KLINIČKOG CENTRA UNIVERZITETA U SARAJEVU: & ANALIZA PODATAKA ZA PERIOD Autor/autori Gavrankapetanović F; Gavrankapetanović I; Bilalović N; Jurić N; Selak I; Radović S; Žutić H; Bešlić Š; Gribajčević M; Junuzović Dž; Tanović H; Kandić Z; Kapidžić A; Kadić N; Dizdarević K; Alender F; Hujić H; Mesihović-Dinarević S; Hadžismajlović A; Piranić H; Mesihović R; Alikadić-Husović A; Fazlić A; Bukvić I; Lončarević N, and Bijedić V Izdavač Vrsta publikacije INIRR Sarajevo znanstveno / stručna knjiga Godina izdavanja Ostvareni projekti (navoditi od posljednjeg ostvarenog projekta) Naziv projekta Vrsta projekta (stručni, naučniistraživački, Prognostička i prediktivna vrijednost imunohistohemijskog određivanja proteina u karcinomu želuca 2010 voditelj domaći Naučnoistraživački Kantonalno Ministarstvo za obrazovanje, nauku, kulturu i sport 10

11 Naziv projekta Vrsta projekta (stručni, naučniistraživački, Banka sperme 2010 učesnik domaći Naučnoistraživački Kantonalno Ministarstvo za obrazovanje, nauku, kulturu i sport Naziv projekta Vrsta projekta (stručni, naučniistraživački, Osnivanje i razvoj tumorske banke 2008 učesnik Domaći Naučnoistraživački Federalno Ministarstvo za obrazovanje, nauku, kulturu i sport Naziv projekta Vrsta projekta (stručni, naučniistraživački, Učestalost i kliničko-patološki značaj koegzistentnih (istovremenih) mutacija PIK3CA i PTEN gena u grupi invazivnih karcinoma dojke sa bazalnim fenotipom 2007 voditelj Domaći Naučnoistraživački Kantonalno Ministarstvo za obrazovanje, nauku, kulturu i sport Naziv projekta Uloga i prognostički značaj stromalnih fibroblasta u invazivnom karcinomu dojke učesnik Domaći 11

12 Vrsta projekta (stručni, naučniistraživački, Naučnoistraživački Federalno Ministarstvo za obrazovanje, nauku, kulturu i sport Naziv projekta Vrsta projekta (stručni, naučniistraživački, Značajimunohistohemijeikliničkihpodatakaudijagnosticimalignihlimfomaklasificiranih por.e.a.l.- Reviziji Evropsko Američke Limfoma Klasifikacije 2001 učesnik Domaći Naučnoistraživački Akademija nauka i umjetnosti BiH Naziv projekta Vrsta projekta (stručni, naučniistraživački, Detekcija Epstein-Barr virusa (EBV) u Hodgkin i non-hodgkin lymphoma u Sarajevskoj regiji učesnik Domaći Naučnoistraživački Akademija nauka i umjetnosti BiH Naziv projekta Vrsta projekta (stručni, naučniistraživački, SHARED / Satelite Health Access for Remote Environment Demonstrator /, telemedicinski projekat baziran na videokonferencijama i videokonsultacijama između San Raffaele Hospital, Milano i Kliničkog Centra, Univerziteta u Sarajevu voditelj Međunarodni Naučnoistraživački-eksperimentalni San Raffaele International Biomedical Science Park sa Stato Maggiore della diffesa and European Space Agency 12

13 8. Mentorstvo (magisteriji, doktorati) Ime i prezime kandidata Naziv teme Husein Čamo KLINIČKI IMUNOFENOTIPSKI PROGNOSTIČKI MARKERI U SOFT TISSUE TUMORIMA Datum odbrane Fakultet/Univerzitet Magisterij/Doktorat Prirodno- matematički fakultet Univerziteta u Sarajevu Magisterij 9. Radionice, tečajevi Naziv Bosnian-British School of Pathology (Bryan Warren School of Pathology) Datum Organizator Voditelj/učesnik British Division of the International Academy of Pathology (BDIAP), United Kingdom and Department of Pathology, Clinical Centre of the University of Sarajevo,Bosnia and Herzegovina Voditelj Naziv Datum Organizator Voditelj/učesnik European Bone Marrow Working GroupBusiness meeting 25-26th June 2006, London, Museum at Charing Cross Hospital,Fulham Palace Road W6 8 RF European Bone Marrow Working Group Učesnik Naziv Datum Pathology of the digestive system: A EuroAmerican course June , Geneva, Switzerland Organizator Voditelj/učesnik Učesnik Naziv Tutorial of Haematopathology Datum Pecs, Hungary, between 9-12 April 2001 Organizator Voditelj/učesnik European Association for Hematopathology Učesnik Naziv Tutorial on the Use of New Techniques in Diagnosis of Malignant Lymphomas Datum Ljubljana 2-5 February 1998 Organizator Institute of Oncology Ljubljana and Medical Center for Molecular Biology of Medical 13

14 Faculty University of Ljubljana Voditelj/učesnik Učesnik Naziv Datum Organizator Voditelj/učesnik Twenty-first International Tutorial on Clinical Cytology Decembar 5-12,1998, Vienna, Austria The Austrian Society of applied Cytology, The American Society of Cytopatology, The European Federation of Cytology Societies, The International Union Against cancer (UICC), The Royal College of Pathologists (UK) Učesnik 10. Poznavanje stranog jezika (EU CEFR) Jezik A1 A2 ( osnovno služenje jezikom) B1 B2 (samostalno služenje jezikom) C1 C2 (kompetentno služenje jezikom) C1-C2 11. Saradnja sa institucijama relevantnim za stručnu ili naučnu oblast General Surgical Pathology, Department of Pathology, Oncology Institute, Ljubljana, Slovenia Department of Pathology, The Norwegian Radium Hospital, Oslo, Norway Toronto General Hospital, Ontario, Canada 12. Predavanja po pozivu Tema Datum Mjesto Institucija 1. 12th Annual Congress of International Drug Discovery Science & Technolog chair in the Session 1162: Infertility & Sterility of the Section 11-6: Women Health while presentingaboutestrogen and Progesterone Recepto rs in Endometrium in Women with Unexplained Infertility November 18-20, 2014 Tongli Lakeview Hotel, Suzhou, China Organizing Committee of IDDST Ekstranodalni limfomi 15. jun 2012 Beograd Uruženje patologa i citologa Srbije 3. Ljetna pedijatrijska škola Sarajevo KLINIČKI ZNAČAJ POVEĆANJA INTRAEPITELNIH LIMFOCITA U DUODENUMU Sarajevo Pedijatrijska Klinika Sarajevo 14

15 13. Recenzije i uredništvo u domaćim i međunarodnim knjigama i časopisima(upisati) Naziv knjige Godina izdavanja Recenzija knjige VODIČ ZA TRETMAN MALIGNOG MELANOMA I PIGMENTNIH PROMJENA KOŽE 2008 Naziv časopisa Broj Recenzija rada Medical Journal (2014) Vol. 20, No. 3, Recenzija rada Medical Journal (2014) Vol. 20, No. 4, Naziv publikacije Period obavljanja funkcije /Datum Uredništvo publikacija Glavni/odgovorni urednik Član redakcijskog odbora Član naučnog odbora 14. Priznanja i pohvale Bilalovic N, Vranic S, Hasanagic S, Basic H,Tatarevic A, Selak I. Cyclin D1 is good prognosticator in breast cancer, Acta clinica Croatica 2004;Vol 43(2): 93-1.(rad nagrađen kao najbolji rad simpozijuma). Notes:15 th Ljudevit Jurak International Symposium on comparative pathology, Juni 4-5, Zagreb, Croatia Bilaloviċ N., Babiċ M., Selak I., Taccagni G.,Paties C., Fontanella G., Telemedicine project (SHARED) in R/F Bosnia and Herzegovina : First results of its use in histopathological diagnosis, Analytical Cellular Pathology Notes :( AWARDED IN OSLO ON THE 5 CONGRESS ESACP) Svojim potpisom odgovorno potvrđujem da su svi podaci koji su objavljeni u Naučnom kartonu pod mojim imenom u cijelosti tačni i provjerljivi Datum Potpis Doc. Dr. Nurija Bilalović 15

NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA Univerzitetski klinički centar u Sarajevu NAUČNI KARTON UPOSLENIKA Institut za naučnoistraživački rad i razvoj 1. Osnovni podaci Prezime TERZIĆ Ime SABINA Godina rođenja 1974. Mjesto rođenja Država rođenja

More information

NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA Univerzitetski klinički centar u Sarajevu NAUČNI KARTON UPOSLENIKA Institut za naučnoistraživački rad i razvoj 1. Osnovni podaci Prezime MEMIĆ-SERDAREVIĆ Ime AMRA Godina rođenja 1976. Mjesto rođenja Država

More information

NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA Univerzitetski klinički centar u Sarajevu NAUČNI KARTON UPOSLENIKA Institut za naučnoistraživački rad i razvoj 1. Osnovni podaci Prezime GODINJAK SLIKA Ime AMINA Godina rođenja 14.03.1982. Mjesto rođenja

More information

NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA Univerzitetski klinički centar u Sarajevu NAUČNI KARTON UPOSLENIKA Institut za naučnoistraživački rad i razvoj 1. Osnovni podaci Prezime BRĐANOVIĆ Ime SNEŽANA Godina rođenja 1963 Mjesto rođenja Država

More information

NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA Univerzitetski klinički centar u Sarajevu NAUČNI KARTON UPOSLENIKA Institut za naučnoistraživački rad i razvoj 1. Osnovni podaci Prezime DURAK-NALBANTIĆ Ime AZRA Godina rođenja 1977 Mjesto rođenja Država

More information

NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA Univerzitetski klinički centar u Sarajevu NAUČNI KARTON UPOSLENIKA Institut za naučnoistraživački rad i razvoj 1. Osnovni podaci Prezime ŠAKOTA-MARIĆ Ime SLAVICA Godina rođenja 1959. Mjesto rođenja Država

More information

NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA 1. Osnovni podaci Prezime Univerzitetski klinički centar u Sarajevu NAUČNI KARTON UPOSLENIKA BEŠLIĆ Institut za naučnoistraživački rad i razvoj Ime NERMINA Godina rođenja 1962. Mjesto rođenja Država rođenja

More information

NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA Univerzitetski klinički centar u Sarajevu NAUČNI KARTON UPOSLENIKA Institut za naučnoistraživački rad i razvoj 1. Osnovni podaci Prezime BEGIĆ Ime AMELA Godina rođenja 1968 Mjesto rođenja Država rođenja

More information

NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA Univerzitetski klinički centar u Sarajevu NAUČNI KARTON UPOSLENIKA Institut za naučnoistraživački rad i razvoj 1. Osnovni podaci Prezime ŠEREMET Ime MENSURA Godina rođenja 1955. Mjesto rođenja Država rođenja

More information

NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA Univerzitetski klinički centar u Sarajevu NAUČNI KARTON UPOSLENIKA Institut za naučnoistraživački rad i razvoj 1. Osnovni podaci Prezime PROHIĆ Ime ASJA Godina rođenja 1961 Mjesto rođenja Država rođenja

More information

NAUČNI KARTON UPOSLENIKA Institut za naučnoistraživački rad i razvoj

NAUČNI KARTON UPOSLENIKA Institut za naučnoistraživački rad i razvoj Univerzitetski klinički centar u Sarajevu NAUČNI KARTON UPOSLENIKA Institut za naučnoistraživački rad i razvoj 1. Osnovni podaci Prezime Vanis Ime Nenad Godina rođenja 1967. Mjesto rođenja Država rođenja

More information

NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA Univerzitetski klinički centar u Sarajevu 1. Osnovni podaci NAUČNI KARTON UPOSLENIKA Institut za naučnoistraživački rad i razvoj Prezime Ime ADNANA TALIĆ-TANOVIĆ Godina rođenja 20.01.1957. Mjesto rođenja

More information

Fuad Džanković IME I PREZIME: DATUM I MJESTO ROĐENJA: docent AKADEMSKO ZVANJE: FAKULTET: Sveučilište Vitez Vitez MAGISTARSKI: DOKTORAT:

Fuad Džanković IME I PREZIME: DATUM I MJESTO ROĐENJA: docent AKADEMSKO ZVANJE: FAKULTET: Sveučilište Vitez Vitez MAGISTARSKI: DOKTORAT: IME I PREZIME: Fuad Džanković DATUM I MJESTO ROĐENJA: 13.06.1961 AKADEMSKO ZVANJE: DATUM, MJESTO I NAZIV docent INSTITUCIJE STICANJA TITULE: FAKULTET: MAGISTARSKI: Sveučilište Vitez Vitez Magistarski rad:

More information

NAUČNI KARTON UPOSLENIKA Institut za naučnoistraživački rad i razvoj

NAUČNI KARTON UPOSLENIKA Institut za naučnoistraživački rad i razvoj Univerzitetski klinički centar u Sarajevu NAUČNI KARTON UPOSLENIKA Institut za naučnoistraživački rad i razvoj 1. Osnovni podaci Prezime Alimanović Halilović Ime Emina Godina rođenja 1956. Mjesto rođenja

More information

Prezime (ime roditelja) i ime Naučni stepen/zvanje. Hasanbegović (Salko) Edo. Datum rođenja Država, mjesto i općina rođenja Organizaciona jedinica

Prezime (ime roditelja) i ime Naučni stepen/zvanje. Hasanbegović (Salko) Edo. Datum rođenja Država, mjesto i općina rođenja Organizaciona jedinica CURRICULUM VITAE Univerzitetski klinički centar u Sarajevu MATIČNI PODACI Prezime (ime roditelja) i ime Naučni stepen/zvanje Hasanbegović (Salko) Edo Telefonski broj(evi) 0038733566428 Doktor medicinskih

More information

Applications of IHC. Determination of the primary site in metastatic tumors of unknown origin

Applications of IHC. Determination of the primary site in metastatic tumors of unknown origin Applications of IHC Determination of the primary site in metastatic tumors of unknown origin Classification of tumors that appear 'undifferentiated' by standard light microscopy Precise classification

More information

Cancers of unknown primary : Knowing the unknown. Prof. Ahmed Hossain Professor of Medicine SSMC

Cancers of unknown primary : Knowing the unknown. Prof. Ahmed Hossain Professor of Medicine SSMC Cancers of unknown primary : Knowing the unknown Prof. Ahmed Hossain Professor of Medicine SSMC Definition Cancers of unknown primary site (CUPs) Represent a heterogeneous group of metastatic tumours,

More information

Personal details: Qualifications:

Personal details: Qualifications: CV Personal details: Full name: Doaa ShamsEl-Din Ahmed Ghorab. Age: 39 years. Date of birth: 10-12-1977 Nationality: Egyptian. Address: Nabil Helaly, flate 5,third floor, El Noha Tower, Ahmad Maher street,

More information

The Pathology of Neoplasia Part II

The Pathology of Neoplasia Part II The Pathology of Neoplasia Part II February 2018 PAUL BOGNER, MD A S S O C I A T E P R O F E S S O R O F O N C O L O G Y P A T H O L O G Y A N D D E R M A T O L O G Y Clinical goals of cancer pathology

More information

NAUČNI KARTON ZDRAVSTVENIH RADNIKA I ZDRAVSTVENIH SURADNIKA KCUS-A

NAUČNI KARTON ZDRAVSTVENIH RADNIKA I ZDRAVSTVENIH SURADNIKA KCUS-A NAUČNI KARTON ZDRAVSTVENIH RADNIKA I ZDRAVSTVENIH SURADNIKA KCUS-A I OSNOVNI PODACI Ime Nihad Prezime Kukavica Godina rođenja 3.2.974. Mjesto rođenja Sarajevo Država Bosna i Hercegovina Zvanje Magistar

More information

Somatostatin receptor SSTR2A and SSTR5 in neuroendocrine breast cancer

Somatostatin receptor SSTR2A and SSTR5 in neuroendocrine breast cancer Somatostatin receptor SSTR2A and SSTR5 in neuroendocrine breast cancer Robert Terlević, MD Melita Perić Balja, MD Davor Tomas, MD, PhD Božo Krušlin, MD, PhD Faruk Skenderi, MD, PhD Semir Vranić, Md, PhD

More information

Angiogenesis in triple-negative adenoid cystic carcinomas of the breast

Angiogenesis in triple-negative adenoid cystic carcinomas of the breast Virchows Arch (2011) 459:377 382 DOI 10.1007/s00428-011-1144-4 ORIGINAL ARTICLE Angiogenesis in triple-negative adenoid cystic carcinomas of the breast Semir Vranic & Snjezana Frkovic-Grazio & Nurija Bilalovic

More information

Research Article Stromal Expression of CD10 in Invasive Breast Carcinoma and Its Correlation with ER, PR, HER2-neu, and Ki67

Research Article Stromal Expression of CD10 in Invasive Breast Carcinoma and Its Correlation with ER, PR, HER2-neu, and Ki67 SAGE-Hindawi Access to Research International Breast Cancer Volume 20, Article ID 47957, 4 pages doi:0.406/20/47957 Research Article Stromal Expression of CD0 in Invasive Breast Carcinoma and Its Correlation

More information

NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA Univerzitetski klinički centar u Sarajevu NAUČNI KARTON UPOSLENIKA Institut za naučnoistraživački rad i razvoj 1. Osnovni podaci Prezime ORUČ Ime LILIJANA Godina rođenja 1955. Mjesto rođenja Država rođenja

More information

From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology. Songlin Zhang, MD, PhD LSUHSC-Shreveport

From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology. Songlin Zhang, MD, PhD LSUHSC-Shreveport From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology Songlin Zhang, MD, PhD LSUHSC-Shreveport I have no Conflict of Interest. FNA on Lymphoproliferative

More information

Oncology 101. Cancer Basics

Oncology 101. Cancer Basics Oncology 101 Cancer Basics What Will You Learn? What is Cancer and How Does It Develop? Cancer Diagnosis and Staging Cancer Treatment What is Cancer? Cancer is a group of more than 100 different diseases

More information

Genetic Testing: When should it be ordered? Julie Schloemer, MD Dermatology

Genetic Testing: When should it be ordered? Julie Schloemer, MD Dermatology Genetic Testing: When should it be ordered? Julie Schloemer, MD Dermatology Outline Germline testing CDKN2A BRCA2 BAP1 Somatic testing Gene expression profiling (GEP) BRAF Germline vs Somatic testing

More information

Cancer: recent advances and implications for underwriting

Cancer: recent advances and implications for underwriting Cancer: recent advances and implications for underwriting Robert Rubens Select 74 Bristol 25 February 2010 Agenda Epidemiology - changing mortality Evidence-base for underwriting breast cancer ovarian

More information

Cancer Genetics. What is Cancer? Cancer Classification. Medical Genetics. Uncontrolled growth of cells. Not all tumors are cancerous

Cancer Genetics. What is Cancer? Cancer Classification. Medical Genetics. Uncontrolled growth of cells. Not all tumors are cancerous Session8 Medical Genetics Cancer Genetics J avad Jamshidi F a s a U n i v e r s i t y o f M e d i c a l S c i e n c e s, N o v e m b e r 2 0 1 7 What is Cancer? Uncontrolled growth of cells Not all tumors

More information

IMMUNOHISTOCHEMICAL EXPRESSION OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 (TIMP-1) IN INVASIVE BREAST CARCINOMA

IMMUNOHISTOCHEMICAL EXPRESSION OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 (TIMP-1) IN INVASIVE BREAST CARCINOMA & IMMUNOHISTOCHEMICAL EXPRESSION OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 (TIMP-1) IN INVASIVE BREAST CARCINOMA Suada Kuskunović*, Svjetlana Radović, Mirsad Dorić, Ajna Hukić, Mirsad Babić, Ivana Tomić,

More information

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management. Hello, I am Maura Polansky at the University of Texas MD Anderson Cancer Center. I am a Physician Assistant in the Department of Gastrointestinal Medical Oncology and the Program Director for Physician

More information

MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site

MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site POLICY: PG0364 ORIGINAL EFFECTIVE: 04/22/16 LAST REVIEW: 07/26/18 MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site GUIDELINES This policy does not certify benefits or authorization

More information

10/15/2012. Biologic Subtypes of TNBC. Topics. Topics. Histopathology Molecular pathology Clinical relevance

10/15/2012. Biologic Subtypes of TNBC. Topics. Topics. Histopathology Molecular pathology Clinical relevance Biologic Subtypes of TNBC Andrea L. Richardson M.D. Ph.D. Brigham and Women s Hospital Dana-Farber Cancer Institute Harvard Medical School Boston, MA Topics Histopathology Molecular pathology Clinical

More information

Review of NEO Testing Platforms. Lawrence M. Weiss, MD Medical Director, Aliso Viejo

Review of NEO Testing Platforms. Lawrence M. Weiss, MD Medical Director, Aliso Viejo Review of NEO Testing Platforms Lawrence M. Weiss, MD Medical Director, Aliso Viejo Lawrence Weiss, M.D. Medical Director, Aliso Viejo Dr. Weiss currently serves as NeoGenomics Medical Director, Aliso

More information

MEDICAL POLICY. Proprietary Information of YourCare Health Plan

MEDICAL POLICY. Proprietary Information of YourCare Health Plan MEDICAL POLICY SUBJECT: HER-2 TESTING IN INVASIVE BREAST OR PAGE: 1 OF: 7 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases,

More information

Recent advances in breast cancers

Recent advances in breast cancers Recent advances in breast cancers Breast cancer is a hetrogenous disease due to distinct genetic alterations. Similar morphological subtypes show variation in clinical behaviour especially in response

More information

Introduction and illustration of the OECI study proposal/feedback of the survey on outcome studies Milena Sant, MD

Introduction and illustration of the OECI study proposal/feedback of the survey on outcome studies Milena Sant, MD Introduction and illustration of the OECI study proposal/feedback of the survey on outcome studies Milena Sant, MD Analytical Epidemiology and Health Impact Unit Department of Preventive and Predictive

More information

Tumor Markers & Cytopathology

Tumor Markers & Cytopathology Tumor Markers & Cytopathology Objectives: After learning, student should be able to 1. Describe the basic concepts of tumor markers and Asst. Prof. Prasit Suwannalert, Ph.D. (Email: prasit.suw@mahidol.ac.th)

More information

Measles and rubella monitoring January 2015

Measles and rubella monitoring January 2015 Measles and rubella monitoring January 215 Reporting on January December 214 surveillance data and epidemic intelligence data to the end of January 215 Main developments Measles During the 12-month period

More information

Case 2. Dr. Sathima Natarajan M.D. Kaiser Permanente Medical Center Sunset

Case 2. Dr. Sathima Natarajan M.D. Kaiser Permanente Medical Center Sunset Case 2 Dr. Sathima Natarajan M.D. Kaiser Permanente Medical Center Sunset History 24 year old male presented with a 3 day history of right flank pain, sharp in nature Denies fever, chills, hematuria or

More information

Barriers to Understanding

Barriers to Understanding Behind the Scenes: The Critical Importance of Cancer Cell Pathology and the Pathologist Sherry T. Emery, M.D., Chief of Pathology Northeast Health System Barriers to Understanding Questions for 2010 What

More information

Sumida T, Hamakawa H. Telomerase and oral cancer. Oral Oncol. 37(4): ,

Sumida T, Hamakawa H. Telomerase and oral cancer. Oral Oncol. 37(4): , Sogawa K, Yamada T, Sumida T, Hamakawa H, Oda H, Tashiro S, Matsuda M, Matsumoto K, Okutani K Induction of K-562 cell apoptosis and inhibitory effect of DNA topoisomerase-i by a marine microalgae G3 polysaccharide.

More information

Cutaneous metastases. Thaddeus Mully. University of California, San Francisco Professor, Departments of Pathology and Dermatology

Cutaneous metastases. Thaddeus Mully. University of California, San Francisco Professor, Departments of Pathology and Dermatology Cutaneous metastases Thaddeus Mully University of California, San Francisco Professor, Departments of Pathology and Dermatology DISCLOSURE OF RELATIONSHIPS WITH INDUSTRY Thaddeus Mully Course C005 Essential

More information

Maram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine

Maram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine Maram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine The most common non-skin malignancy of women 2 nd most common cause of cancer deaths in women, following

More information

Tumor Markers Yesterday, Today & Tomorrow. Steven E. Zimmerman M.D. Vice President & Chief Medical Director

Tumor Markers Yesterday, Today & Tomorrow. Steven E. Zimmerman M.D. Vice President & Chief Medical Director Tumor Markers Yesterday, Today & Tomorrow Steven E. Zimmerman M.D. Vice President & Chief Medical Director Tumor Marker - Definition Substances produced by cancer cells or other cells in response to cancer

More information

Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers

Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers 日大医誌 75 (1): 10 15 (2016) 10 Original Article Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers Naotaka Uchida 1), Yasuki Matsui 1), Takeshi Notsu 1) and Manabu

More information

Summary Report Report on Cancer Statistics in Alberta. February Surveillance and Health Status Assessment Cancer Surveillance

Summary Report Report on Cancer Statistics in Alberta. February Surveillance and Health Status Assessment Cancer Surveillance Summary Report 2008 Report on Cancer Statistics in Alberta February 2011 November 25, 2011 ERRATUM: Summary Report, 2008 Report on Cancer Statistics in Alberta There was an error in the spelling of prostate

More information

Tumour Markers. For these reasons, only a handful of tumour markers are commonly used by most doctors.

Tumour Markers. For these reasons, only a handful of tumour markers are commonly used by most doctors. Tumour Markers What are Tumour Markers? Tumour markers are substances that can be found in the body when cancer is present. They are usually found in the blood or urine. They can be products of cancer

More information

A CASE OF PRIMARY THYROID LYMPHOMA. Prof Dr.Dilek Gogas Yavuz Marmara University School of Medicine Endocrinology and Metabolism Istanbul, Turkey

A CASE OF PRIMARY THYROID LYMPHOMA. Prof Dr.Dilek Gogas Yavuz Marmara University School of Medicine Endocrinology and Metabolism Istanbul, Turkey A CASE OF PRIMARY THYROID LYMPHOMA Prof Dr.Dilek Gogas Yavuz Marmara University School of Medicine Endocrinology and Metabolism Istanbul, Turkey 38 year old female She recognized a mass in her right neck

More information

NEW IHC A n t i b o d i e s

NEW IHC A n t i b o d i e s NEW IHC Antibodies TABLE OF CONTENTS NEW IHC ANTIBODIES from Cell Marque CITED1 (5H6).... 1 Claudin 7 (5D10F3).... 1 GATA1 (4F5).... 1 Transgelin (2A10C2).... 1 NEW IHC ANTIBODIES using RabMAb Technology

More information

2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a Pseudocapsule

2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a Pseudocapsule GENITOURINARY PATHOLOGY Kathleen M. O Toole, M.D. Renal Cell Carcinoma 2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow Necrotic Mass Grossly is a Bright

More information

CALL FOR A EUROPEAN ACTION PLAN FOR MEDICAL IMAGING TO IMPROVE QUALITY OF CARE AND PATIENT SAFETY

CALL FOR A EUROPEAN ACTION PLAN FOR MEDICAL IMAGING TO IMPROVE QUALITY OF CARE AND PATIENT SAFETY CALL FOR A EUROPEAN ACTION PLAN FOR MEDICAL IMAGING TO IMPROVE QUALITY OF CARE AND PATIENT SAFETY myesr.org QUALITY & SAFETY Improving and harmonising quality and safety in medical imaging across Europe

More information

PAAF vs Core Biopsy en Lesiones Mamarias Case #1

PAAF vs Core Biopsy en Lesiones Mamarias Case #1 5/19/2014 PAAF vs Core Biopsy en Lesiones Mamarias Case #1 Fine Needle Aspiration Cytology of Breast: Correlation with Needle Core Biopsy 64-year-old woman Mass in breast Syed Hoda, MD CD31 Post-Radiation

More information

Localized Prostate Cancer Have we finally got it right? Shingai Mutambirwa Professor & Chair-Division Urology DGMAH & SMU Pretoria SOUTH AFRICA

Localized Prostate Cancer Have we finally got it right? Shingai Mutambirwa Professor & Chair-Division Urology DGMAH & SMU Pretoria SOUTH AFRICA Localized Prostate Cancer Have we finally got it right? Shingai Mutambirwa Professor & Chair-Division Urology DGMAH & SMU Pretoria SOUTH AFRICA ESMO Cape Town 14 Feb 2018 Disclosures Advisory boards/lecturer/consultant-

More information

Mesothelioma: diagnostic challenges from a pathological perspective. Naseema Vorajee August 2016

Mesothelioma: diagnostic challenges from a pathological perspective. Naseema Vorajee August 2016 Mesothelioma: diagnostic challenges from a pathological perspective Naseema Vorajee August 2016 Naseema.vorajee@nhls.ac.za Pleural diseases (whether neoplastic, reactive or infective) may have similar

More information

Claudin-4 Expression in Triple Negative Breast Cancer: Correlation with Androgen Receptors and Ki-67 Expression

Claudin-4 Expression in Triple Negative Breast Cancer: Correlation with Androgen Receptors and Ki-67 Expression Claudin-4 Expression in Triple Negative Breast Cancer: Correlation with Androgen Receptors and Ki-67 Expression Mona A. Abd-Elazeem, Marwa A. Abd- Elazeem Pathology department, Faculty of Medicine, Tanta

More information

List of Available TMAs in the PRN

List of Available TMAs in the PRN TMA RPCI_BrainCa01 RPCI_BrCa03 RPCI_BrCa04 RPCI_BrCa05 RPCI_BrCa0 RPCI_BrCa07 RPCI_BrCa08 RPCI_BrCa15 RPCI_BrCa1 RPCI_BrCa17 RPCI_BrCa18 RPCI_BrCa19 RPCI_BrCa20 RPCI_BrCa21 RPCI_BrCa24 RPCI_BrCa25 RPCI_BrCa2

More information

Institute for Cancer Genetics and Informatics

Institute for Cancer Genetics and Informatics Organization Institute for Cancer Genetics and Informatics Annual Report 217 The Institute for Cancer Genetics and Informatics, ICGI, is a department at Oslo University Hospital (OUS), located at the Norwegian

More information

Quality Control/Quality Assurance in Diagnostic Immunohistochemistry

Quality Control/Quality Assurance in Diagnostic Immunohistochemistry CIHRT Exhibit P- Page Quality Control/Quality Assurance in Diagnostic Immunohistochemistry Emina Torlakovic, MD, PhD College of Medicine University of Saskatchewan Emina Emilia Torlakovic, MD, PhD Associate

More information

Mu ath M.A. Rjoub Supervised by: Dr. Huda Zahawi, FRCPath. King Abdullah University Hospital )KAUH(

Mu ath M.A. Rjoub Supervised by: Dr. Huda Zahawi, FRCPath. King Abdullah University Hospital )KAUH( Mu ath M.A. Rjoub Supervised by: Dr. Huda Zahawi, FRCPath. King Abdullah University Hospital )KAUH( Clinical History A 56 year old single female, presented complaining of postmenopausal bleeding. She underwent

More information

Immunohistochemical classification of lung carcinomas and mesotheliomas. Prof. Mogens Vyberg NordiQC Institute of Pathology Aalborg, Denmark

Immunohistochemical classification of lung carcinomas and mesotheliomas. Prof. Mogens Vyberg NordiQC Institute of Pathology Aalborg, Denmark Immunohistochemical classification of lung carcinomas and mesotheliomas Prof. Mogens Vyberg NordiQC Institute of Pathology Aalborg, Denmark Endobronchial ultrasound guided transbronchial needle biopsy

More information

Adenoid cystic carcinomas of the breast have low Topo IIα expression but frequently overexpress EGFR protein without EGFR gene amplification

Adenoid cystic carcinomas of the breast have low Topo IIα expression but frequently overexpress EGFR protein without EGFR gene amplification Human Pathology (2010) 41, 1617 1623 www.elsevier.com/locate/humpath Original contribution Adenoid cystic carcinomas of the breast have low Topo IIα expression but frequently overexpress EGFR protein without

More information

NAUČNI KARTON ZDRAVSTVENIH RADNIKA I ZDRAVSTVENIH SURADNIKA KCUS-A

NAUČNI KARTON ZDRAVSTVENIH RADNIKA I ZDRAVSTVENIH SURADNIKA KCUS-A NAUČNI KARTON ZDRAVSTVENIH RADNIKA I ZDRAVSTVENIH SURADNIKA KCUS-A I OSNOVNI PODACI Ime Dželaludin Prezime Junuzović Godina rođenja 1955 Mjesto rođenja Sarajevo Država Bosna i Hercegovina Zvanje prof.

More information

Monitoring Metastatic Breast Cancer with Serum HER-2/neu: Individual Patient Profiles

Monitoring Metastatic Breast Cancer with Serum HER-2/neu: Individual Patient Profiles Siemens Healthcare Diagnostics, a global leader in clinical diagnostics, provides healthcare professionals in hospital, reference, and physician office laboratories and point-of-care settings with the

More information

The European Commission s science and knowledge service. Joint Research Centre

The European Commission s science and knowledge service. Joint Research Centre The European Commission s science and knowledge service Joint Research Centre Coding Primary Site and Tumour Morphology JRC-ENCR training course Copenhagen, 25 September 2018 Nadya Dimitrova Outline What

More information

Slide seminar. Asist. Prof. Jože Pižem, MD, PhD Institute of Pathology Medical Faculty, University of Ljubljana

Slide seminar. Asist. Prof. Jože Pižem, MD, PhD Institute of Pathology Medical Faculty, University of Ljubljana Slide seminar Asist. Prof. Jože Pižem, MD, PhD Institute of Pathology Medical Faculty, University of Ljubljana Case 5 A 57-year-old man with a dermal/subcutaneous lesion on the scalp, which was interpreted

More information

THE BURDEN OF CANCER IN NEBRASKA: RECENT INCIDENCE AND MORTALITY DATA

THE BURDEN OF CANCER IN NEBRASKA: RECENT INCIDENCE AND MORTALITY DATA THE BURDEN OF CANCER IN NEBRASKA: RECENT INCIDENCE AND MORTALITY DATA Presented by: Bryan Rettig, MS Nebraska Dept. of Health & Human Services Division of Public Health May 31, 2017 Nebraska Cancer Registry

More information

ACCME/Disclosures. Case History 4/13/2016. USCAP GU Specialty Conference Case 3. Ann Arbor, MI

ACCME/Disclosures. Case History 4/13/2016. USCAP GU Specialty Conference Case 3. Ann Arbor, MI USCAP GU Specialty Conference Case 3 March 2016 L. Priya Kunju, M.D. University of Michigan Health System Ann Arbor, MI University of Michigan Health System ACCME/Disclosures The USCAP requires that anyone

More information

2018 Surgical Pathology Update: Diagnostic Pearls for the Practicing Pathologist - Volume II

2018 Surgical Pathology Update: Diagnostic Pearls for the Practicing Pathologist - Volume II Release Date: January 1, 15.25 AMA PRA Category 1 Credit(s) TM About This CME Teaching Activity This CME Activity is designed to provide a comprehensive review of soft tissue, gastrointestinal, genitourinary,

More information

IBCM 2, April 2009, Sarajevo, Bosnia and Herzegovina

IBCM 2, April 2009, Sarajevo, Bosnia and Herzegovina Preoperative diagnosis and treatment planning in breast cancer The pathologist s perspective L. Mazzucchelli Istituto Cantonale di Patologia Locarno, Switzerland IBCM 2, 23-25 April 2009, Sarajevo, Bosnia

More information

A 53 year-old woman with a lung mass, right hilar mass and mediastinal adenopathy.

A 53 year-old woman with a lung mass, right hilar mass and mediastinal adenopathy. November 2015 Case of the Month A 53 year-old woman with a lung mass, right hilar mass and mediastinal adenopathy. Contributed by: Rasha Salama, M.D., IU Department of Pathology and Laboratory Medicine

More information

Breast pathology. 2nd Department of Pathology Semmelweis University

Breast pathology. 2nd Department of Pathology Semmelweis University Breast pathology 2nd Department of Pathology Semmelweis University Breast pathology - Summary - Benign lesions - Acute mastitis - Plasma cell mastitis / duct ectasia - Fat necrosis - Fibrocystic change/

More information

NAUČNI KARTON ZDRAVSTVENIH RADNIKA I ZDRAVSTVENIH SURADNIKA KCUS-A

NAUČNI KARTON ZDRAVSTVENIH RADNIKA I ZDRAVSTVENIH SURADNIKA KCUS-A NAUČNI KARTON ZDRAVSTVENIH RADNIKA I ZDRAVSTVENIH SURADNIKA KCUS-A I OSNOVNI PODACI Ime MIRSAD Prezime KACILA Godina rođenja 1965. Mjesto rođenja SARAJEVO Država BOSNA I HERCEGOVINA Zvanje Vanredni profesor

More information

Cancer Mortality, Recent Trends And Perspectives

Cancer Mortality, Recent Trends And Perspectives & Cancer Mortality, Recent Trends And Perspectives Dragana Nikšić¹*, Amira Kurspahić-Mujičić¹, Aida Pilav², Haris Nikšić³ 1. Social Medicine Institute, Faculty of Medicine, University of Sarajevo, Čekaluša

More information

Urinary Bladder: WHO Classification and AJCC Staging Update 2017

Urinary Bladder: WHO Classification and AJCC Staging Update 2017 Urinary Bladder: WHO Classification and AJCC Staging Update 2017 Houston Society of Clinical Pathologists 58 th Annual Spring Symposium Houston, TX April 8, 2017 Jesse K. McKenney, MD Classification

More information

Cleveland Clinic Laboratories. Anatomic Pathology

Cleveland Clinic Laboratories. Anatomic Pathology Cleveland Clinic Laboratories Anatomic Pathology OUR MISSION Cleveland Clinic Laboratories contributes to excellent patient care by providing high-quality, comprehensive laboratory testing and patient-focused

More information

ACCME/Disclosures. Diagnosing Mesothelioma in Limited Tissue Samples. Papanicolaou Society of Cytopathology Companion Meeting March 12 th, 2016

ACCME/Disclosures. Diagnosing Mesothelioma in Limited Tissue Samples. Papanicolaou Society of Cytopathology Companion Meeting March 12 th, 2016 Diagnosing Mesothelioma in Limited Tissue Samples Papanicolaou Society of Cytopathology Companion Meeting March 12 th, 2016 Sanja Dacic, MD, PhD University of Pittsburgh ACCME/Disclosures GENERAL RULES

More information

Presentation material is for education purposes only. All rights reserved URMC Radiology Page 1 of 98

Presentation material is for education purposes only. All rights reserved URMC Radiology Page 1 of 98 Presentation material is for education purposes only. All rights reserved. 2011 URMC Radiology Page 1 of 98 Radiology / Pathology Conference February 2011 Brooke Koltz, Cytopathology Resident Presentation

More information

Case year old female presented with asymmetric enlargement of the left lobe of the thyroid

Case year old female presented with asymmetric enlargement of the left lobe of the thyroid Case 4 22 year old female presented with asymmetric enlargement of the left lobe of the thyroid gland. No information available relative to a prior fine needle aspiration biopsy. A left lobectomy was performed.

More information

Carcinoma mammario: le istologie non frequenti. Valentina Guarneri Università di Padova IOV-IRCCS

Carcinoma mammario: le istologie non frequenti. Valentina Guarneri Università di Padova IOV-IRCCS Carcinoma mammario: le istologie non frequenti Valentina Guarneri Università di Padova IOV-IRCCS Histological diversity of breast adenocarcinomas Different histological types are defined according to specific

More information

Case 4 Diagnosis 2/21/2011 TGB

Case 4 Diagnosis 2/21/2011 TGB Case 4 22 year old female presented with asymmetric enlargement of the left lobe of the thyroid gland. No information available relative to a prior fine needle aspiration biopsy. A left lobectomy was performed.

More information

NPQR Quality Payment Program (QPP) Measures 21_18247_LS.

NPQR Quality Payment Program (QPP) Measures 21_18247_LS. NPQR Quality Payment Program (QPP) Measures 21_18247_LS MEASURE ID: QPP 99 MEASURE TITLE: Breast Cancer Resection Pathology Reporting pt Category (Primary Tumor) and pn Category (Regional Lymph Nodes)

More information

NEOPLASIA. 3. Which of the following tumour is benign a. Chondrosarcoma b. Osteochondroma c. Chondroblastoma d. Ewing s tumour e.

NEOPLASIA. 3. Which of the following tumour is benign a. Chondrosarcoma b. Osteochondroma c. Chondroblastoma d. Ewing s tumour e. NEOPLASIA 1. malignant neoplasms a. are independent of hormonal influence b. are always composed of homogenous cell lines c. arise from differentiated cells by a process of anaplasia d. display abnormal

More information

Triple Negative Breast Cancer

Triple Negative Breast Cancer Triple Negative Breast Cancer Prof. Dr. Pornchai O-charoenrat Division of Head-Neck & Breast Surgery Department of Surgery Faculty of Medicine Siriraj Hospital Breast Cancer Classification Traditional

More information

The role of the cytologist in breast cancer screening

The role of the cytologist in breast cancer screening The role of the cytologist in breast cancer screening I.Seili-Bekafigo, MD, PhD Clinical cytologist KBC Rijeka Croatian Society for Clinical Cytology Fine needle aspiration (FNA, FNAB, FNAC) Fine needle

More information

RSNA, /radiol Appendix E1. Methods

RSNA, /radiol Appendix E1. Methods RSNA, 2016 10.1148/radiol.2016151097 Appendix E1 Methods US and Near-infrared Data Acquisition Four optical wavelengths (740 nm, 780 nm, 808 nm, and 830 nm) were used to sequentially deliver the light

More information

Surgical Oncology/Clinical Center Sarajevo - Sarajevo, Bosnia and Herzegovina

Surgical Oncology/Clinical Center Sarajevo - Sarajevo, Bosnia and Herzegovina - Sarajevo, Bosnia and Herzegovina General Information New breast cancer cases treated per year 200 Breast multidisciplinarity team members 24 Radiologists, surgeons, pathologists, medical oncologists,

More information

CODING TUMOUR MORPHOLOGY. Otto Visser

CODING TUMOUR MORPHOLOGY. Otto Visser CODING TUMOUR MORPHOLOGY Otto Visser INTRODUCTION The morphology describes the tissue of the tumour closest to normal tissue Well differentiated tumours are closest to normal Undifferentiated tumours show

More information

Diploma Examination. Dermatopathology: First paper. Tuesday 20 March Candidates must answer FOUR questions. Time allowed: 3 hours

Diploma Examination. Dermatopathology: First paper. Tuesday 20 March Candidates must answer FOUR questions. Time allowed: 3 hours Dermatopathology: First paper Tuesday 20 March 2018 Candidates must answer FOUR questions Time allowed: 3 hours 1. Give an account of the genetic aberrations encountered in Spitzoid neoplasms and how these

More information

Disclosure. Relevant Financial Relationship(s) None. Off Label Usage None MFMER slide-1

Disclosure. Relevant Financial Relationship(s) None. Off Label Usage None MFMER slide-1 Disclosure Relevant Financial Relationship(s) None Off Label Usage None 2013 MFMER slide-1 Case Presentation A 43 year old male, with partial nephrectomy for a right kidney mass 2013 MFMER slide-2 2013

More information

Problems in staging breast carcinoma

Problems in staging breast carcinoma Problems in staging breast carcinoma Primary systemic therapy (PST) of breast carcinoma pathologists tasks Dr. Janina Kulka, 2nd Department of Pathology, Semmelweis University Budapest Austro-Hungarian

More information

RESPIRATORY SOCIETY IN BOSNIA AND HERZEGOVINA Bardakčije 90, Sarajevo, Bosnia i Herzegovina

RESPIRATORY SOCIETY IN BOSNIA AND HERZEGOVINA Bardakčije 90, Sarajevo, Bosnia i Herzegovina RESPIRATORY SOCIETY IN BOSNIA AND HERZEGOVINA Bardakčije 90, 71000 Sarajevo, Bosnia i Herzegovina http://www.pulmo.co.ba IV CONGRESS OF RESPIRATORY SOCIETY IN BOSNIA AND HERZEGOVINA Scientific Agenda Thursday,

More information

Enterprise Interest None

Enterprise Interest None Enterprise Interest None B3 lesions of the breast What are they at surgery? Case 4 Edi Brogi MD PhD Attending Pathologist - Director of Breast Pathology Memorial Sloan Kettering Cancer Center New York

More information

Clinical indications for positron emission tomography

Clinical indications for positron emission tomography Clinical indications for positron emission tomography Oncology applications Brain and spinal cord Parotid Suspected tumour recurrence when anatomical imaging is difficult or equivocal and management will

More information

Identification of Potential Therapeutic Targets by Molecular and Genomic Profiling of 628 Cases of Uterine Serous Carcinoma

Identification of Potential Therapeutic Targets by Molecular and Genomic Profiling of 628 Cases of Uterine Serous Carcinoma Identification of Potential Therapeutic Targets by Molecular and Genomic Profiling of 628 Cases of Uterine Serous Carcinoma Nathaniel L Jones 1, Joanne Xiu 2, Sandeep K. Reddy 2, Ana I. Tergas 1, William

More information

Case 18. M75. Excision of mass on scalp. Clinically SCC. The best diagnosis is:

Case 18. M75. Excision of mass on scalp. Clinically SCC. The best diagnosis is: Case 18 M75. Excision of mass on scalp. Clinically SCC. The best diagnosis is: A. Pilomatrical carcinoma B. Adnexal carcinoma NOS C. Metastatic squamous cell carcinoma D.Primary squamous cell carcinoma

More information

Surgical Pathology Lab of the Future. Thomas M. Grogan, M.D. Professor of Pathology, University of Arizona Founder, Ventana Medical Systems, Inc.

Surgical Pathology Lab of the Future. Thomas M. Grogan, M.D. Professor of Pathology, University of Arizona Founder, Ventana Medical Systems, Inc. Surgical Pathology Lab of the Future Thomas M. Grogan, M.D. Professor of Pathology, University of Arizona Founder, Ventana Medical Systems, Inc. 28 April 2010 Objective Demonstrate how the next generation

More information

Molecular Characterization of Breast Cancer: The Clinical Significance

Molecular Characterization of Breast Cancer: The Clinical Significance Molecular Characterization of : The Clinical Significance Shahla Masood, M.D. Professor and Chair Department of Pathology and Laboratory Medicine University of Florida College of Medicine-Jacksonville

More information

Diploma examination. Dermatopathology: First paper. Tuesday 21 March Candidates must answer FOUR questions ONLY. Time allowed: Three hours

Diploma examination. Dermatopathology: First paper. Tuesday 21 March Candidates must answer FOUR questions ONLY. Time allowed: Three hours Dermatopathology: First paper Tuesday 21 March 2017 1. Discuss the role of fluorescent in-situ hybridization (FISH) and emerging molecular techniques in the diagnosis of cutaneous melanocytic lesions,

More information

Quality Assurance and Quality Control in the Pathology Dept.

Quality Assurance and Quality Control in the Pathology Dept. Quality Assurance and Quality Control in the Pathology Dept. Judith Sandbank M.D. Pathology Assaf-Harofeh Medical Center ISRAEL jsandbank@asaf.health.gov.il 2 nd IBDC, 9 th February, 2012 Pathology as

More information